About Us Services Careers FAQ Contact Us 0
Home Medical Devices Pain Management Devices Market Size, Demand & Growth Report | 2031

Pain Management Devices Market Size, Share & Trends Analysis Report By Type (Neuromodulation and neurostimulation devices, Analgesic infusion pumps, Ablation devices), By Applications (Cancer pain, Neuropathic pain, Facial and migraine pain, Musculoskeletal pain, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRMD3438DR
Last Updated : August 12, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Pain Management Devices Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Neuromodulation and neurostimulation devices
        1. By Value
      3. Analgesic infusion pumps
        1. By Value
      4. Ablation devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Cancer pain
        1. By Value
      3. Neuropathic pain
        1. By Value
      4. Facial and migraine pain
        1. By Value
      5. Musculoskeletal pain
        1. By Value
      6. Others
        1. By Value
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Neuromodulation and neurostimulation devices
        1. By Value
      3. Analgesic infusion pumps
        1. By Value
      4. Ablation devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Cancer pain
        1. By Value
      3. Neuropathic pain
        1. By Value
      4. Facial and migraine pain
        1. By Value
      5. Musculoskeletal pain
        1. By Value
      6. Others
        1. By Value
    4. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Neuromodulation and neurostimulation devices
          1. By Value
        3. Analgesic infusion pumps
          1. By Value
        4. Ablation devices
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Cancer pain
          1. By Value
        3. Neuropathic pain
          1. By Value
        4. Facial and migraine pain
          1. By Value
        5. Musculoskeletal pain
          1. By Value
        6. Others
          1. By Value
    5. Canada
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Neuromodulation and neurostimulation devices
        1. By Value
      3. Analgesic infusion pumps
        1. By Value
      4. Ablation devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Cancer pain
        1. By Value
      3. Neuropathic pain
        1. By Value
      4. Facial and migraine pain
        1. By Value
      5. Musculoskeletal pain
        1. By Value
      6. Others
        1. By Value
    4. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Neuromodulation and neurostimulation devices
          1. By Value
        3. Analgesic infusion pumps
          1. By Value
        4. Ablation devices
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Cancer pain
          1. By Value
        3. Neuropathic pain
          1. By Value
        4. Facial and migraine pain
          1. By Value
        5. Musculoskeletal pain
          1. By Value
        6. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Neuromodulation and neurostimulation devices
        1. By Value
      3. Analgesic infusion pumps
        1. By Value
      4. Ablation devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Cancer pain
        1. By Value
      3. Neuropathic pain
        1. By Value
      4. Facial and migraine pain
        1. By Value
      5. Musculoskeletal pain
        1. By Value
      6. Others
        1. By Value
    4. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Neuromodulation and neurostimulation devices
          1. By Value
        3. Analgesic infusion pumps
          1. By Value
        4. Ablation devices
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Cancer pain
          1. By Value
        3. Neuropathic pain
          1. By Value
        4. Facial and migraine pain
          1. By Value
        5. Musculoskeletal pain
          1. By Value
        6. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Singapore
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Neuromodulation and neurostimulation devices
        1. By Value
      3. Analgesic infusion pumps
        1. By Value
      4. Ablation devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Cancer pain
        1. By Value
      3. Neuropathic pain
        1. By Value
      4. Facial and migraine pain
        1. By Value
      5. Musculoskeletal pain
        1. By Value
      6. Others
        1. By Value
    4. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Neuromodulation and neurostimulation devices
          1. By Value
        3. Analgesic infusion pumps
          1. By Value
        4. Ablation devices
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Cancer pain
          1. By Value
        3. Neuropathic pain
          1. By Value
        4. Facial and migraine pain
          1. By Value
        5. Musculoskeletal pain
          1. By Value
        6. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Neuromodulation and neurostimulation devices
        1. By Value
      3. Analgesic infusion pumps
        1. By Value
      4. Ablation devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Cancer pain
        1. By Value
      3. Neuropathic pain
        1. By Value
      4. Facial and migraine pain
        1. By Value
      5. Musculoskeletal pain
        1. By Value
      6. Others
        1. By Value
    4. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Neuromodulation and neurostimulation devices
          1. By Value
        3. Analgesic infusion pumps
          1. By Value
        4. Ablation devices
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Cancer pain
          1. By Value
        3. Neuropathic pain
          1. By Value
        4. Facial and migraine pain
          1. By Value
        5. Musculoskeletal pain
          1. By Value
        6. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Pain Management Devices Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott Laboratories
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Boston Scientific Corp
    3. Medtronic Plc.
    4. B Braun Melsungen AG
    5. Baxter International Inc.
    6. Colfax Corporation (DJO Global LLC)
    7. Stryker Corp.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global airway management devices market size was valued at USD 1.7 billion in 2023 and is projected to reach USD 2.8 billion by 2032, registering a CAGR of 5.2% during the forecast period (2024-2032). The increasing frequency of respiratory disor
Buy Now
Global Report
API Management Market SizeThe global API management market size was valued at USD 1.16 billion in 2021. It is expected to reach USD 7.02 billion, growing at a CAGR of 22.15% during the forecast period (2022–2030). Companies can expand their market po
Buy Now
Global Report
The global management decision market size was valued at USD 5.8 Billion in 2022, presumed to reach USD 25.6 Billion, expanding at a CAGR of 16.12% during the forecast period.  Management decision refers to the management's assessment of the co
Buy Now
Global Report
Pain Management Therapeutics Market Size The global pain management therapeutics market size was valued at USD 79.42 billion in 2023 and is projected to reach USD 115.21 billion by 2032, growing at a CAGR of 4.22% during the
Buy Now
Global Report
Market Overview The global parking management market size was valued at USD 4.56 billion in 2022 and is projected to reach USD 11.48 billion by 2031, registering a CAGR of 10.8% during the forecast period 2023-2031. Parking managemen
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.